← Back to patent-cliff list
CAS 74-95-3
Dibromomethane
Codes: Cilastatin Sodium-026
Application context (from source-drug indications)
Infectious diseaseCilastatin Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Cilastatin Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Methyl 3,3-dimethylacrylate→Dibromomethane→Methyl 2,2-dimethylcyclopropane-1-carboxylate→2,2-Dimethylcyclopropane-1-carboxylic acid→2,2-Dimethylcyclopropane-1-carbonyl chloride→(S)-2,2-Dimethylcyclopropanecarboxylic acid→Ethyl 2-diazoacetate→2-Methyl-1-propene→Ethyl (1S)-2,2-dimethylcyclopropane-1-carboxylate→(4R)-4-(1-methylcycloprop-2-en-1-yl)-2-(1-((R)-4-(tert-pentyl)-4,5-dihydrooxazol-2-yl)-1-tritetracontaoxidanylethyl)-4,5-dihydrooxazole
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.